Patients Waiting Months for 'Last Chance' CAR T-Cell Therapy

Supply shortages and limited manufacturing capacity are leaving myeloma patients waiting months for CAR T-cell therapy, which offers a "last chance" after all other therapies have failed.
Medscape Medical News

source https://www.medscape.com/viewarticle/977179?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost